Works matching IS 03656233 AND DT 2024 AND VI 357 AND IP 4
Results: 18
Cover Picture: Arch Pharm (4/2024).
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202470030
- Publication type:
- Article
Issue Information: Arch Pharm (4/2024).
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202470029
- Publication type:
- Article
Indole clubbed 2,4‐thiazolidinedione linked 1,2,3‐triazole as a potent antimalarial and antibacterial agent against drug‐resistant strain and molecular modeling studies.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300673
- By:
- Publication type:
- Article
Development and evaluation of 2,4‐disubstituted‐5‐aryl pyrimidine derivatives as antibacterial agents.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300656
- By:
- Publication type:
- Article
On the hunt for metalloenzyme inhibitors: Investigating the presence of metal‐coordinating compounds in screening libraries and chemical spaces.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300648
- By:
- Publication type:
- Article
Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300631
- By:
- Publication type:
- Article
Novel radioiodinated desvenlafaxine‐loaded lipid nanocapsule for brain delivery.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300618
- By:
- Publication type:
- Article
Structure‐guided design of potent JAK1‐selective inhibitors based on 4‐amino‐7H‐pyrrolo[2,3‐d]pyrimidine with anti‐inflammatory efficacy.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300591
- By:
- Publication type:
- Article
Inhibitory effect of galantamine and donepezil combination against cholinesterase: An in silico and in vitro study.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300581
- By:
- Publication type:
- Article
Immunomodulatory activities and biomedical applications of melittin and its recent advances.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300569
- By:
- Publication type:
- Article
Combating DC‐SIGN‐mediated SARS‐CoV‐2 dissemination by glycan‐mimicking polymers.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300396
- By:
- Publication type:
- Article
Triazole derivatives as potential xanthine oxidase inhibitors: Design, enzyme inhibition potential, and docking studies.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300296
- By:
- Publication type:
- Article
Synthesis and evaluation of febrifugine derivatives as anticoccidial agents.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300540
- By:
- Publication type:
- Article
Biaryl carboxamide‐based peptidomimetics analogs as potential pancreatic lipase inhibitors for treating obesity.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300503
- By:
- Publication type:
- Article
Benzothiazole‐based apoptosis inducers: A comprehensive overview and future prospective.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300493
- By:
- Publication type:
- Article
Synthesis of 2‐(pyridylvinyl)chromen‐4‐ones and their N‐oxide analogs for assessment of their biological activities as anticancer agents.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300445
- By:
- Publication type:
- Article
Design, synthesis, and biological evaluation of naphthoylamide derivatives as inhibitors of STAT3 phosphorylation.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300526
- By:
- Publication type:
- Article
Identification and assessment of new PIM2 inhibitors for treating hematologic cancers: A combined approach of energy‐based virtual screening and machine learning evaluation.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 4, p. 1, doi. 10.1002/ardp.202300516
- By:
- Publication type:
- Article